The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Pfizer Inc

NYSE: PFE
Last

(U.S.) $35.35

Today's change+1.01 +2.94%
Updated July 28 4:00 PM EDT. Delayed by at least 15 minutes.
 

Pfizer Inc

NYSE: PFE
Last

(U.S.) $35.35

Today's change+1.01 +2.94%
Updated July 28 4:00 PM EDT. Delayed by at least 15 minutes.

Pfizer Inc Hits New 50-day High

Pfizer Inc closed up sharply Tuesday, rallying (U.S.)$1.01 or 2.94% to (U.S.)$35.35 and setting a new 50-day high. Over the last five days, shares have gained 0.60% and 13.48% year to date. Shares have outperformed the S&P 500 by 11.66% during the last year.

Key company metrics

  • Open(U.S.) $34.94
  • Previous close(U.S.) $34.34
  • High(U.S.) $35.47
  • Low(U.S.) $34.40
  • Bid / Ask-- / --
  • YTD % change+13.48%
  • Volume36,671,126
  • Average volume (10-day)20,337,802
  • Average volume (1-month)22,148,478
  • Average volume (3-month)22,413,507
  • 52-week range(U.S.) $27.51 to (U.S.) $35.53
  • Beta0.74
  • Trailing P/E24.45×
  • P/E 1 year forward16.83×
  • Forward PEG4.37×
  • Indicated annual dividend(U.S.) $1.12
  • Dividend yield3.17%
  • Trailing EPS(U.S.) $1.45
Updated July 28 4:00 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+18.79%

Based on its net profit margin of 18.79%, Pfizer Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.54%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2015Q4/2014Q3/2014Q2/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 29, 201503/29/2015Dec 31, 201412/31/2014Sep 28, 201409/28/2014Jun 29, 201406/29/2014
Revenue10,86413,11812,36112,773
Total other revenue--------
Total revenue10,86413,11812,36112,773
Gross profit9,03510,43310,00610,327
Total cost of revenue1,8292,6852,3552,446
Total operating expense7,70111,2158,6218,599
Selling / general / administrative3,1043,9813,5563,520
Research & development1,8853,2091,8021,759
Depreciation / amortization9409499721,001
Interest expense (income), net operating--------
Unusual expense (income)17053126595
Other operating expenses, total-227-140-329-222
Operating income3,1631,9033,7404,174
Interest income (expense), net non-operating-309-353-343-343
Gain (loss) on sale of assets175215333
Other--------
Income before tax3,0821,8033,5874,003
Income after tax2,3761,2582,6762,921
Income tax, total7065459111,082
Net income2,3751,2292,6672,912
Total adjustments to net income0-1-1-1
Net income before extra. items2,3701,2512,6702,912
Minority interest-6-7-6-9
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items2,3701,2502,6692,911
Inc. avail. to common incl. extra. items2,3751,2282,6662,911
Diluted net income2,3751,2282,6662,912
Dilution adjustment0----1
Diluted weighted average shares6,2926,3736,4036,444
Diluted EPS excluding extraordinary itemsvalue per share0.380.200.420.45
Dividends per sharevalue per share0.280.260.260.26
Diluted normalized EPSvalue per share0.370.280.450.45